Dermata Therapeutics Inc (DRMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Operating Expenses | 1,812 | 1,732 | 2,278 | 1,712 | 2,446 |
| Operating Income | -1,812 | -1,732 | -2,278 | -1,712 | -2,446 |
| Other Income | 93 | 31 | 38 | 42 | 22 |
| Pre-tax Income | -1,719 | -1,701 | -2,240 | -1,670 | -2,425 |
| Net Income Continuous | -1,719 | -1,701 | -2,240 | -1,670 | -2,425 |
| Net Income | $-1,719 | $-1,701 | $-2,240 | $-1,670 | $-2,425 |
| EPS Basic Total Ops | -80.90 | -94.30 | -340.33 | -226.39 | -473.76 |
| EPS Basic Continuous Ops | -80.89 | -94.35 | -340.67 | -224.95 | -473.76 |
| EPS Diluted Total Ops | -80.90 | -94.30 | -340.33 | -226.39 | -473.76 |
| EPS Diluted Continuous Ops | -80.89 | -94.35 | -340.67 | -224.95 | -473.76 |
| EBITDA(a) | $-1,812 | $-1,732 | $-2,278 | $-1,712 | $-2,446 |